We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: EUPROTEIN offers custom development and production of bioresearch reagents (Photo courtesy of EUPROTEIN)

Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities

Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA). More...
03 May 2022
Image: L Squared Capital Partners has acquired Globe Scientific (Photo courtesy of Pexels)

Globe Scientific Acquired by L Squared Capital Partners

Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings. More...
02 May 2022
Image: Xpert MTB/RIF proved to be a game-changer in the TB epidemic (Photo courtesy of Cepheid)

Study Examines Global Rollout of Rapid Molecular Tests for TB Over Last 12 Years

Diagnostic tests only have an impact on health if they are put to use in a correct and timely manner. To ensure diagnostics are accessible and utilized, a new qualitative evidence synthesis review has pulled together all relevant research to date on rapid molecular tests for tuberculosis and tuberculosis drug resistance. More...
27 Apr 2022
Image: Rising prevalence of chronic diseases is driving the global POCT market (Photo courtesy of Pexels)

Global Point-of-Care Testing (POCT) Market to Surpass USD 55 Billion by 2030

The global point of care testing (POCT) market was valued at USD 29.47 billion in 2020 and is expected to grow at a CAGR of 6.5% from 2021 to 2030 to reach USD 55.27 billion by 2030, driven by a rise in the prevalence of chronic diseases such as diabetes, rheumatism, and cancer and several supportive initiatives implemented by government and non-government organizations. More...
19 Apr 2022
Image: bioMérieux has entered into an agreement to acquire Specific Diagnostics (Photo courtesy of Pexels)

BioMérieux Acquires Antibiotic Susceptibility Test Firm Specific Diagnostics

bioMérieux (Marcy-l'Étoile, France) has further strengthened its commitment to fight AMR with the acquisition of Specific Diagnostics (San Jose, CA, USA) which focuses on fast AST solution and has developed a rapid AST system that delivers phenotypic AST directly from positive blood cultures. More...
13 Apr 2022
Image: Global HAI testing kits market will be driven by increased chronic diseases (Photo courtesy of Unsplash)

Global Hospital Acquired Infections Testing Kits Market to Reach USD 1.8 Billion by 2026

The global hospital acquired infections testing kits market is expected to grow at a CAGR of 12.7% from USD 1.12 billion in 2021 to USD 1.27 billion in 2022 and is projected to grow further at a CAGR of 8.8% to USD 1.78 billion in 2026, driven by increased incidence of chronic diseases. More...
08 Apr 2022
Image: Global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 (Photo courtesy of Unsplash)

Global Clinical Chemistry Analyzer Market Driven by Higher Testing Volume and Shorter TAT Due to Automation

In recent decades, the clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. As a result, the global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 and is anticipated to grow at a CAGR of 4.8% over the forecast period (2022-2030). More...
28 Mar 2022
Visit expo >
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Automated Blood Typing System
IH-500 NEXT
New
Urine cfDNA Extraction Kit
CloNext Urine cfDNA Extraction Kit
New
Cortisol/Cortisone Saliva Controls
MassCheck Chromsystems Saliva Controls

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2024 Globetech Media.
All rights reserved.